Category Archives: Retina
On Demand Webinar: The New Management of IRD Patients in the Era of Gene Therapy – A Team Approach
Jul 27th, 2021
Learning Webinar Available on Demand A medical education program for a broad Canadian medical audience focused on inherited retinal diseases and gene therapy. It will include 6 short talks (~ 10 min each) on IRD patient journey + Panel discussion on the Multidisciplinary Management of a IRD patient. Archived Webinar Content When to suspect an […]
Inherited Retinal Dystrophies, Clinical Breakthroughs and Gene Replacement Therapies: Entering a New Era of Medicine
Jul 21st, 2021
Description This is an Educational Webinar Series available on demand. There are Series of 3 webinars focusing on inherited retinal disease presented by Canadian experts discussing inherited retinal dystrophies from symptoms, to diagnosis and treatment options. The role of genetic screening and genetic counseling as part of the patient journey are also presented. Each of […]
22nd International Society for Genetic Eye Diseases and Retinoblastoma (ISGEDR) Meeting
Jul 14th, 2021
22nd ISGEDR Meeting, will be held hybrid (virtual and in person) from September 2nd to 4th 2021 in Lausanne, Switzerland, jointly with the European Retinoblastoma Group (EURbG), the Société de Génétique Ophtalmologique Francophone (SGOF), and the European Reference Network dedicated to Rare Eye Diseases (ERN-EYE). The scientific program promises to be outstanding, covering the hotest topics in ocular […]
Peut-on réapprendre à voir quand on a perdu la vision ? | Cynthia Qian | TEDxUmontreal
Jul 13th, 2021
Dr. Cynthia Qian presents two revolutionary methods to help people with inherited retinal diseases to regain their vision. Gene therapy for young children whose disease is at an early stage, and the bionic eye for people who may have completely lost their sight. Blindness is no longer a fatality. Explanation in video.
WHO’s Diabetic Retinopathy screening: a short guide (2020)
Dec 1st, 2020
November, 2020 This guide is designed for policy-makers, public health leaders and senior clinicians involved in planning, designing and implementing diabetic retinopathy screening programmes in the WHO European Region. The purpose of screening is to identify people with diabetes who are at higher risk of developing sight-threatening diabetic retinopathy so that early treatment or intervention […]
Virtual Retina Case Conference Canada 2020
Nov 17th, 2020
Virtual Retina Case Conference Canada 2020 will take place on Saturday, November 21. While cases for presentation are no longer being accepted, registration for the meeting is still open. Join your colleagues for a day of interactive case discussions mixed with presentations from our guest lecturers, Dr. Carl Regillo from Wills Eye and Dr. Wai-Ching […]
RETINA CONNECT: The Ambiguity of Pachychoroid
Oct 23rd, 2020
Date: October 27, 2020 Time: 7:30 PM – 8:30 PM Title: The Ambiguity of Pachychoroid Speaker: Dr. Rick Spaide, Vitreous Retina Macula Consultants of New York Panelist: Nadia Waheed, Tufts University Zoom Link: https://us02web.zoom.us/j/85794432915?pwd=T0Z1NGN5eFMxdXFsbFp2UG9yVmEwQT09Passcode: connect
Webinar: Challenges in Vitreoretinal Surgery
Oct 20th, 2020
Challenges in Vitreoretinal surgery The Calgary Ophthalmology Program and University of Calgary are organizing an online CME webinar as part of their retina grand rounds on October 21st from 7 pm to 8:30 pm ET (5 pm to 6:30 pm MT). Short intraoperative videos demonstrating challenging vitreoretinal surgeries will be presented by retina surgeons and […]
Webinar- Innovative Treatment Trends in Neovascular Age-Related Macular Degeneration and Diabetic Retinopathy
Sep 11th, 2020
Date: Wednesday , Sep 23, 2020 Time: 7:00 PM – 8:00 PM EDT Target Audience:The intended audience for this activity is ophthalmologists and other health care professionals involved in the management of patients with neovascular age-related macular degeneration and diabetic retinopathy. Overview:Visual outcomes in patients with neovascular age-related macular degeneration (nAMD) and diabetic retinopathy (DR) […]